Does ENZALUTAMIDE Cause Product physical consistency issue? 6 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Product physical consistency issue have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.0% of all adverse event reports for ENZALUTAMIDE.
6
Reports of Product physical consistency issue with ENZALUTAMIDE
0.0%
of all ENZALUTAMIDE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product physical consistency issue From ENZALUTAMIDE?
Of the 6 reports.
Is Product physical consistency issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Product physical consistency issue?
LEUPROLIDE (926)
CLASCOTERONE (317)
BUPRENORPHINE (242)
MINOXIDIL (171)
CHOLESTYRAMINE (141)
NAPROXEN (117)
TESTOSTERONE (113)
RUXOLITINIB (103)
DEVICE (85)
CLOBETASOL (76)
Which ENZALUTAMIDE Alternatives Have Lower Product physical consistency issue Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE